3,3'-Dichlorobiphenyl (PCB 11) alters the hepatic expression of cytochrome P450 enzymes in the liver of mouse dams exposed orally during pregnancy and lactation
Authors:
- Crystal M. RoachCRCrystal M. Roach
- Nate R. KoesterNKNate R. Koester
- Xueshu LiXLXueshu Li
- Jeonghyeon AhnJAJeonghyeon Ahn
- R. Marshall PopeRPR. Marshall Pope
- Rebecca J. WilsonRWRebecca J. Wilson
- Rosalia MendietaRMRosalia Mendieta
- Anthony ValenzuelaAVAnthony Valenzuela
- Weiguo HanWHWeiguo Han
- Pamela J. LeinPamela J. Lein
- Hans-Joachim LehmlerHLHans-Joachim Lehmler
Open Access
- 8 December 2025
- journal article
- toxicokinetics and-metabolism
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (3) , 943-957
Abstract
Healthy maternal metabolism is critical during pregnancy and lactation to support fetal development and protect against environmental toxins. Polychlorinated biphenyl 11 (PCB 11), a lower-chlorinated, non-legacy congener, is detected in human serum, including pregnant women and children; however, its impact during these sensitive life stages remains poorly understood. This study presents the first comprehensive hepatic proteome analysis of mouse dams exposed to PCB 11 during pregnancy and lactation. Female C57BL/6 J mice received daily oral doses of PCB 11 (0, 1.0 or 6.0 mg/kg) prior to conception through lactation. At postpartum day 21, brain, liver, and serum samples were analyzed for PCB 11 and its metabolites, and hepatic proteomic changes were assessed. Low detection of PCB 11 and its metabolites was observed in tissues, suggesting rapid clearance. Metabolite screening revealed OH-PCB 11, PCB 11 sulfate, and OH-PCB 11 sulfate metabolites in serum. Global proteomics identified significant alterations in hepatic protein expression, including downregulation of cytochrome P450 enzymes, solute carriers, and enzymes involved in fatty acid and steroid metabolism. Pathway enrichment analyses indicated disruptions in xenobiotic metabolism and endocrine pathways. These findings suggest that PCB 11 exposure during pregnancy and lactation impairs hepatic detoxification and metabolic capacity, potentially compromising maternal and offspring health. This work highlights the need for further investigation into the long-term consequences of PCB 11 exposure during pregnancy and lactation.Keywords
Funding Information
- National Institute of Environmental Health Sciences (R01ES014901)
- National Institute of Environmental Health Sciences (R01ES031098)
- National Institute of Environmental Health Sciences (R01ES034691)
- National Institute of Environmental Health Sciences (P30ES005605)
- National Institute of Environmental Health Sciences (P42ES013661)
This publication has 56 references indexed in Scilit:
- The xenobiotic detoxification pathway - glycine conjugation - is downregulated in a mouse model of Leigh syndromeBiochemical and Biophysical Research Communications, 2025
- Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liverActa Pharmaceutica Sinica B, 2021
- Important Issues in Planning a Proteomics Experiment: Statistical Considerations of Quantitative Proteomic Data2021
- 3,3ʹ-Dichlorobiphenyl (PCB 11) promotes dendritic arborization in primary rat cortical neurons via a CREB-dependent mechanismArchives of Toxicology, 2018
- Authentication of synthetic environmental contaminants and their (bio)transformation products in toxicology: polychlorinated biphenyls as an exampleEnvironmental Science and Pollution Research, 2018
- Potent mutagenicity of some non-planar tri- and tetrachlorinated biphenyls in mammalian cells, human CYP2E1 being a major activating enzymeArchives of Toxicology, 2016
- Environmental Fate and Global Distribution of Polychlorinated Biphenyls2009
- Partitioning and levels of neutral organochlorine compounds in human serum, blood cells, and adipose and liver tissueScience of The Total Environment, 1991
- PCBs and PBBs: Biologic and toxic effects on C57BL/6J and DBA/2J inbred miceToxicology, 1984
- Metabolism of dichlorobiphenyls by hepatic microsomal cytochrome P-450Biochemical Pharmacology, 1981